Four integrated technologies for Biologics developability assessment

December 13, 2022

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics.

Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development.

The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability, and aggregation, which enables better pipeline decisions.

Learn more about how Prometheus Panta helps biologics researchers.

Previous Video
How 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta
How 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta

Discover how 2bind applied multi-parameter characterization from a single experiment to find the optimal bu...

Up next
Your guide to efficiently develop antibody-based therapeutics
Your guide to efficiently develop antibody-based therapeutics

How to measure stability, why it's important, and where it belongs in the workflow

Want to see more
biologics content?

Explore resources